-
GLCCI1 polymorphism rs37973 and asthma treatment response to inhaled corticosteroids [Elektronski vir]Rijavec, Matija ...Background. Asthma treatment response is highly variable and pharmacogenetic markers that predict treatment response would be one step closer to personalized treatment. GWAS studies have shown that ... polymorphisms GLCCI1 could be associated with asthma treatment response to inhaled corticosteroids (ICS). Materials and methods. We genotyped rs37973 of GLCCI1 in 208 adult asthma patients treated with ICS. Change in % predicted FEV1 was analysed after short-term (3 months) and after long-term (at least 3 years) treatment. Treatment success was defined as good when FEV1 decreased less than 30 ml/year. Results. After 3 months of treatment, change of % predicted FEV1 was higher in patients with GG genotype than in patients with AG+AA genotype, and this genotype dependent difference was only evident in non-smokers. Similar results were found after at least 3 years of treatment when all patients were analysed, in non-smokers and patients with atopy. Even though, no differences in treatment success (good vs. poor response) were observed when analysing the entire group of patients, genotype dependent treatment success was highly influenced by smoking and atopy. GG genotype was overrepresented in non-smokers and patients with atopy with good response. Conclusions. Rs37973 was associated with short- and long-term treatment response; however, there was a great influence of smoking and atopy on pharmacogenetic association. Furthermore, we found GG genotype to be associated with better treatment response, what is contrary to results found in GWAS.Vir: Journal of investigational allergology & clinical immunology [Elektronski vir]. - ISSN 1698-0808 (Vol. 28, iss. 3, 2018, str. 165-171)Vrsta gradiva - e-članek ; neleposlovje za odrasleLeto - 2018Jezik - angleškiCOBISS.SI-ID - 2048262769
Avtor
Rijavec, Matija |
Žavbi, Mateja |
Lopert, Anton |
Fležar, Matjaž |
Korošec, Peter, 1970-
Teme
Asthma |
Diagnosis |
Therapy |
Pharmacogenetics |
Polymorphism, genetic |
Smoking |
Astma |
Diagnostika |
Terapija |
Farmakogenetika |
Genetski polimorfizem |
Kajenje |
inhaled corticosteroids |
atopy |
GLCCI1 |
FEV1 |
rs37973 |
inhalacijski kortikosteroidi |
atopija
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Rijavec, Matija | 29300 |
Žavbi, Mateja | 33192 |
Lopert, Anton | |
Fležar, Matjaž | 15710 |
Korošec, Peter, 1970- | 22807 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.